Russia to start using Avifavir as a Covid-19 treatment from June

Kirill Dmitriev, CEO of the Russian Direct Investment Fund — Russia's sovereign wealth fund — discusses the development of Avifavir, a drug the country has approved to be delivered to hospitals for use in Covid-19 patients from June.